The antimalarials quinacrine and chloroquine induce weak lysosomal storage of sulphated glycosaminoglycans in cell culture and in vivo
- 17 June 1996
- journal article
- research article
- Published by Elsevier in Toxicology
- Vol. 110 (1-3) , 27-37
- https://doi.org/10.1016/0300-483x(96)03319-7
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Drug-induced lysosomal storage of sulfated glycosaminoglycans. Studies on the underlying structure-activity relationshipsToxicology, 1993
- Induction of mucopolysaccharidosis in rats by treatment with immunostimulatory acridine derivativesToxicology and Applied Pharmacology, 1992
- Lysosomal storage of sulfated glycosaminoglycans in cultured fibroblasts exposed to immunostimulatory acridine derivativesToxicology and Applied Pharmacology, 1992
- Drug-induced lysosomal storage of sulfated glycosaminoglycans in cultured bovine and human fibroblastsVirchows Archiv B Cell Pathology Including Molecular Pathology, 1991
- Mucopolysaccharidosis and lipidosis in rats treated with tilorone analoguesToxicology, 1989
- Tilorone Acts as a Lysosomotropic Agent in FibroblastsHoppe-Seyler´s Zeitschrift Für Physiologische Chemie, 1984
- Chloroquine inhibits lysosomal enzyme pinocytosis and enhances lysosomal enzyme secretion by impairing receptor recycling.The Journal of cell biology, 1980
- UV-induced changes in lysosomes tagged with quinacrineExperimental Cell Research, 1966
- Uptake of dyes and drugs by living cells in cultureLife Sciences, 1964
- SPECIFIC STAINING OF SULPHATE GROUPS WITH ALCIAN BLUE AT LOW pHJournal of Histochemistry & Cytochemistry, 1964